HANCOCK JAFFE PE Ratio 2017-2019 | HJLI

Current and historical p/e ratio for HANCOCK JAFFE (HJLI) from 2017 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. HANCOCK JAFFE PE ratio as of January 28, 2020 is 0.00.
HANCOCK JAFFE PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-01-28 0.49 0.00
2019-09-30 0.85 $-0.36 0.00
2019-06-30 1.04 $-0.39 0.00
2019-03-31 1.56 $-1.32 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.008B $0.000B
Hancock Jaffe Laboratories, Inc. is involved in developing and manufacturing bioprosthetic medical devices to treat cardiac and vascular diseases. Its product candidates consists of the porcine tissue based VenoValve, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency; CoreoGraft?, a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery and a porcine tissue based heart valve, is an ideal candidate for pediatric aortic/mitral valve replacement. Hancock Jaffe Laboratories, Inc. is based in IRVINE, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.924B 38.83
Takeda Pharmaceutical (TAK) Japan $61.813B 9.77
Astellas Pharma (ALPMY) Japan $32.875B 16.42
Eisai (ESALY) Japan $21.999B 42.41
Merck (MKGAF) Germany $16.989B 23.18
Grifols, S.A (GRFS) Spain $15.869B 20.79
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $9.133B 431.17
Catalent (CTLT) United States $9.010B 36.65
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Ionis Pharmaceuticals (IONS) United States $8.358B 16.93
Jazz Pharmaceuticals (JAZZ) Ireland $8.245B 10.53
STADA ARZNEIMI (STDAF) Germany $5.972B 0.00
IPSEN SA ADR (IPSEY) France $5.862B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.282B 16.07
Arrowhead Pharmaceuticals (ARWR) United States $4.270B 64.65
Evotec AG (EVTCY) Germany $4.074B 65.85
United Therapeutics (UTHR) United States $3.920B 0.00
Nektar Therapeutics (NKTR) United States $3.717B 0.00
FibroGen (FGEN) United States $3.647B 107.18
Sage Therapeutics (SAGE) United States $3.525B 0.00
PTC Therapeutics (PTCT) United States $3.200B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.198B 11.77
ChemoCentryx (CCXI) United States $2.396B 0.00
Zogenix (ZGNX) United States $2.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.119B 0.00
Heron Therapeutics (HRTX) United States $2.035B 0.00
Tilray (TLRY) Canada $1.985B 0.00
Xencor (XNCR) United States $1.947B 59.19
Ironwood Pharmaceuticals (IRWD) United States $1.940B 61.85
Pacira Pharmaceuticals (PCRX) United States $1.828B 54.09
USANA Health Sciences (USNA) United States $1.608B 17.16
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.492B 18.13
Theravance Biopharma (TBPH) Cayman Islands $1.487B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.415B 9.65
Endo (ENDP) Ireland $1.343B 2.47
Enanta Pharmaceuticals (ENTA) United States $1.087B 24.71
Portola Pharmaceuticals (PTLA) United States $1.062B 0.00
Karyopharm Therapeutics (KPTI) United States $1.036B 0.00
Dermira (DERM) United States $1.020B 0.00
Aerie Pharmaceuticals (AERI) United States $0.996B 0.00
Akebia Therapeutics (AKBA) United States $0.943B 0.00
Radius Health (RDUS) United States $0.870B 0.00
Collegium Pharmaceutical (COLL) United States $0.702B 0.00
TherapeuticsMD (TXMD) United States $0.673B 0.00
Flexion Therapeutics (FLXN) United States $0.671B 0.00
ImmunoGen (IMGN) United States $0.659B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.547B 0.00
Molecular Templates (MTEM) United States $0.501B 0.00
Translate Bio (TBIO) United States $0.483B 0.00
Ardelyx (ARDX) United States $0.467B 0.00
Organogenesis Holdings (ORGO) United States $0.459B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.437B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.434B 0.00
Innate Pharma SA (IPHYF) France $0.432B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.422B 0.00
Siga Technologies (SIGA) United States $0.418B 9.56
BioCryst Pharmaceuticals (BCRX) United States $0.417B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.415B 17.91
Catalyst Pharmaceuticals (CPRX) United States $0.410B 49.75
DURECT (DRRX) United States $0.385B 0.00
OptiNose (OPTN) United States $0.371B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
Recro Pharma (REPH) United States $0.361B 0.00
Lannett Co Inc (LCI) United States $0.361B 4.20
Harpoon Therapeutics (HARP) United States $0.360B 0.00
Rafael Holdings (RFL) United States $0.345B 0.00
Indivior (INVVY) United States $0.335B 1.21
KalVista Pharmaceuticals (KALV) United States $0.305B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.259B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.258B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.256B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.239B 0.00
MEI Pharma (MEIP) United States $0.237B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
IMV INC (IMV) Canada $0.212B 0.00
Jounce Therapeutics (JNCE) United States $0.210B 2.80
La Jolla Pharmaceutical (LJPC) United States $0.206B 0.00
Nature's Sunshine Products (NATR) United States $0.193B 33.23
Taiwan Liposome (TLC) Taiwan $0.176B 0.00
Xeris Pharmaceuticals (XERS) United States $0.155B 0.00
CannTrust Holdings (CTST) Canada $0.150B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.139B 0.00
Redhill Biopharma (RDHL) Israel $0.131B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.121B 0.00
CV Sciences (CVSI) United States $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Otonomy (OTIC) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.095B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.094B 0.00
PolarityTE (PTE) United States $0.091B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.088B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Infinity Pharmaceuticals (INFI) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.73
CTI BioPharma (CTIC) United States $0.074B 0.00
RENEURON GP (RNUGF) United Kingdom $0.074B 0.00
AgeX Therapeutics (AGE) United States $0.067B 0.00
Aclaris Therapeutics (ACRS) United States $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.062B 15.39
Nivalis Therapeutics (ALPN) United States $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
IsoRay (ISR) United States $0.056B 0.00
Onconova Therapeutics (ONTX) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Jaguar Animal Health (JAGX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Biomerica (BMRA) United States $0.030B 0.00
PharmAthene (ALT) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
VAXART, INC (VXRT) United States $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
Novan (NOVN) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.012B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
Heat Biologics (HTBX) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00